Prohost Biotech – Exclusive Biotech Research

Exclusive Market Insight

& Scientific analysis

  • Exclusive Posts
  • Industry Newsletters
  • Clinical Trials
  • Possible Takeovers
  • Technology of the Week
  • Stock Table
  • Therapeutic Vaccines
  • Development-Stage Firms
  • Genomics
  • Prohost Picks
  • And much more...
Menu
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • The Week in Review
  • Prohost Letters
  • Login / Register
    • Login
    • Register
    • Contact Us
  • Impacting News
  • News & Comments
  • Today’s Highlights
  • Trick or Trade
  • The Week in Review
  • Prohost Letters
  • Login / Register
    • Login
    • Register
    • Contact Us

Cassava Sciences: Good News During Bad Market Days

February 23, 2021 0
The market is sinking in a furious mood caused by the failure to figure out the pathway of criteria, which is currently controlling the stocks’ volatile performances. Today we are posting good news coming from a few biotech companies with solid fundamentals. Unfortunately, all of these firms are tumbling instead of soaring, or at least performing positively. Look for them …

Novavax is Bringing its COVID-19 Vaccine to the World’s Markets

Vir Biotechnology and GlaxoSmithKline Expanded Agreement

Researchers at the Children’s Hospital of Philadelphia are Improving Gene...

Moderna COVID-19 Vaccine Produced Neutralizing Titers Against Key Emerging Variants...

Exelixis: The FDA Approved Cabometyx in Combination with Opdivo as...

Regenxbio: Advancing its Gene Therapy Pipeline and its Rare Neurodegenerative...

Gilead Sciences has Good News for Relapsed or Refractory Mantle...

Regenxbio Announced the First Patient has been Dosed in the...

Moderna’s Successful COVID-19 Vaccine Results

Moderna’s Future Growth

Pfizer and BioNTech Vaccine Candidate Against COVID-19 Achieved a Sweet...

Imminent Announcements of Important Quarterly Results

Tracking the News from AstraZeneca About Experimental Vaccine, AZD1222, for...

The U.S. FDA Approves Gilead Sciences Antiviral Veklury® (remdesivir) for...

Ionis Pharmaceuticals News About ALS Treatment Attempts

Tracking COVID-19 Vaccines

Enlivex Therapeutics Product AllocetraTM Saves Severe/Critical COVID-19 Patients

Gilead Sciences Could Acquire Immunomedics at $20 Billion. See Also:...

Sanofi and GlaxoSmithKLine COVID-19 Vaccines are Advancing in Clinical Trial

Impacting News

Compugen: Good News During Bad Market Days

February 23, 2021 0
The market is sinking in a furious mood caused by the failure to figure out the …

Regeneron Pharmaceuticals: Good News During Bad Market Days

February 23, 2021 0
The market is sinking in a furious mood caused by the failure to figure out the …

Is There a Possible Comeback for Nektar Therapeutics?

February 18, 2021 0
Nektar Therapeutics YoYoing Stock Price Investors who exaggerate their enthusiasm, or their apathy, towards buying and …

Regeneron Has Much Good News. Is the Market Paying Attention?

February 12, 2021 0
Regeneron Pharmaceuticals Approval of EvkeezaTM for HoFH Regeneron Pharmaceuticals (REGN) has a series of good news …

Amgen is Still the King of the Biotech Sector

January 30, 2021 0
Amgen KRAS Inhibitor, Sotorasib Amgen (AMGN) has taken on one of the toughest challenges in the last …

Aurinia Pharmaceuticals: FDA Approved LUPKYNIS for Active Lupus Nephritis in Adults  

January 27, 2021 0
Aurinia Pharmaceuticals LUPKYNIS Approved for LN in Adults Aurinia Pharmaceuticals (AUPH) has been granted a U.S. …

Trick or Trade

The Reasons for the Immunome, Inc Stock Rally

February 18, 2021 0
Immunome, Inc. Immunome, Inc (IMNM) announced today that its discovery engine has isolated potent antibodies capable …

News About Reata Pharmaceuticals

January 19, 2021 0
Reata Pharmaceuticals The Positive News  Prohost Biotech’s interest in Reata Pharmaceuticals (RETA) started when we recognized …

A New COVID-19 Vaccine is Showing Successful Results. See Also: More Details About the Effective COVID-19 Vaccines

November 23, 2020 0
COVID-19 Vaccine Updates Pfizer’s (PFE)/BioNTech’s (BNTX) and Moderna’s (MRNA) COVID-19 vaccines have demonstrated safety at around …

SARS-CoV-2 Virus vs The President of the United States

October 5, 2020 0
President Trump, the First Lady and COVID-19 Indeed, the complicated, nasty SARS-CoV-2 virus managed to infect …

Sorrento Therapeutics Releases Preclinical Data from STI-1499 and STI-2020 Demonstrating Potent Neutralizing Antibodies Against SARS-CoV-2

September 29, 2020 0
Sorrento Therapeutics Preclinical Data of Neutralizing Antibodies Against SARS-CoV-2 In preclinical studies, both STI-1499 and STI-2020 …

Agenus: Could It Be a Resurrection? See Also: Prohost Performing Stocks

September 2, 2020 0
Agenus Announced Data from Phase 2 Trials of Balstilimab Agenus (AGEN) immuno-oncology company announced that data …

Today’s Highlights

bluebird bio Temporarily Suspends Studies of LentiGlobin Gene Therapy for SCD. See Also: Cellectis is Outperforming

February 17, 2021 0
bluebird bio Suspends LentiGlobin Studies bluebird bio (BLUE) placed its Phase 1/2 (HGB-206) and Phase 3 …

Why Cassava Sciences Stock Opened Down Today. See Also: The Mirati Therapeutics and MD Anderson Collaboration

February 10, 2021 2
Cassava Sciences Inc Opened Down Today Cassava Sciences, Inc. (SAVA) - a clinical-stage biotech firm focused on …

Cassava Sciences: Significant Program Progress and its Expected Milestones for 2021

February 8, 2021 0
Cassava Sciences 2021 Focus and Momentum Cassava Sciences (SAVA) President & CEO, Remi Barbier, informed that …

Roche and Spark Therapeutics: Gene Therapy SPK-8016 Demonstrating Promising Results on Adults with Severe Hemophilia A

February 5, 2021 0
Roche Group and Spark Therapeutics Gene Therapy Showing Promising Results Looking for gene therapy treatments for …

Cassava Sciences Product, Simufilam, Improved the Cognition and Behavior of Alzheimer’s Patients Following Six Months of Treatment

February 2, 2021 2
Cassava Sciences Announced Simufilam Results for Alzheimer's Cassava Sciences (SAVA) announced impressive results of an interim …

CASI Partner, BioInvent, Announced the Combination of Rituximab with BI-1206 restored riruximab’s Capability to Treat Indolent Relapsed or Refractory B-cell non-Hodgkin’s Lymphoma

January 28, 2021 0
CASI Pharmaceuticals Partner, BioInvent International, Announced Positive Interim Results for NHL CASI Pharmaceuticals (CASI) partner BioInvent …

The Week in Review

Questions & Answers

May 27, 2020 0
The Week in Review #51 Questions & Answers About CytomX Q: Is there any reason for …
The World Focus is on COVID-19 Treatments and Vaccines

The World Focus is on COVID-19 Treatments and Vaccines

April 20, 2020 0
The Week in Review #50 The World FOCUS is COVID-19 The world FOCUS right now is …
Stars Before the Coronavirus Outbreak and Those Firms Treating COVID-19

Stars Before the Coronavirus Outbreak and Those Firms Treating COVID-19

March 24, 2020 0
The Week in Review #49 The Stars from the Weeks Preceding the Novel Coronavirus Outbreak  Forty …
The Week in Review #48 ~ Holiday Edition

The Week in Review #48 ~ Holiday Edition

December 27, 2019 0
The Week in Review #48 Holiday Edition ******************** Merry Christmas and Happy Hanukkah! We Wish You …
What A Week For Biotechnology

What A Week For Biotechnology

November 11, 2019 0
The Week in Review #47 What A Week For Biotechnology Synopsis In this “Week in Review” …
The Quarterly Financial Results

The Quarterly Financial Results

November 4, 2019 0
The Week in Review #46 The Quarterly Financial Results The quarterly financial results that analysts and …

Prohost Letters

The Biotechnology Industry

December 8, 2020 2
Prohost Letter #443 The Biotechnology Industry The Biotechnology Industry revolutionized the arts of life sciences with …

The Whole World Against the Blind SARS-CoV-2 Virus

September 28, 2020 3
Prohost Letter 442 The Whole World Against the Blind SARS-CoV-2 Virus Investors have no doubt profited …

Are We Saying Goodbye to Common Sense?

July 3, 2020 2
Prohost Letter #441 Biotechnology Companies’ Evaluations Are We Saying Goodbye to Common Sense? The SARS-CoV-2 Vaccines …

Novel Coronavirus: The Therapeutics

May 11, 2020 0
Prohost Letter #440 Coronavirus The Therapeutics Gilead’s Remdesivir Treating COVID-19 patients requires therapeutic products that can …
Prohost Letter #439

Prohost Letter #439

February 19, 2020 0
Prohost Letter #439 The Coronavirus Outbreak - COVID-19 The news announced that the coronavirus (now known …
Prohost Letter #438 ~ The End of the Year Issue 2019

Prohost Letter #438 ~ The End of the Year Issue 2019

January 1, 2020 0
Prohost Letter #438 End of the Year Issue  2019 Happy New Year 2020 The NASDAQ reached …

Search ProhostBiotech

Popular Links

Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) Editas Medicine Inc (EDIT) Enanta (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeuctics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seattle Genetics (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex (VRTX) Xoma (XOMA)
  • Recent

ProhostBiotech Archive

Sign Up for Weekly Emails

Prohost Biotech – Exclusive Biotech Research Copyright © 2021.
© 2014 Prohost Biotech. All rights reserved.

Privacy Policy | Cancellation Policy | Forward Looking Statement